Jan 17 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd
* Says two Shanghai-based pharmaceutical units received drug clinical trials approval for injection FN-1501, which is mainly used for treatment of leukemia
Source text in Chinese: goo.gl/22foMq
Further company coverage: (Beijing Headline News)
 